An outbreak of Serratia marcescens was seen on a pulmonary ward from September 1999 until September 2000. During this period, there were two distinct clusters of S. marcescens isolation. In the first episode, September-October 1999, S. marcescens isolates with the same resistance pattern were isolated in 10 patients. PFGE (pulsed-field gel electrophoresis) following digestion with SpeI confirmed that these isolates were identical. After an initial decline in the number of isolates, the incidence rose again in March 2000. The resistance pattern of these isolates differed from that in 1999. PFGE showed that most of the isolates in 2000 were identical and had replaced the previous strain (strain 1). In the second episode, January-August 2000, 26 patients were colonized with the subsequent strain (strain 2). Three of these patients had serious clinical problems due to S. marcescens, two had bacteraemia and one empyema. In September 2000, strain 2 was also detected in stock solutions for inhalation therapy. After discontinuation of the use of stock solutions and emphasizing hygienic measures, the outbreak resolved. The majority (68%) of the patients positive for S. marcescens suffered from COPD (chronic obstructive pulmonary disease). PFGE results suggest that several COPD patients were carriers of the same strain of S. marcescens for a prolonged time. Re-admission of these patients could have lead to re-introduction of the epidemic strains.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1053/jhin.2002.1313 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Molecular epidemiology of β-lactamases in ceftriaxone-resistant Enterobacterales bloodstream infections in the mid-Atlantic United States.
Antimicrob Agents Chemother
January 2025
Department of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
Ceftriaxone-resistant Enterobacterales remain a public health threat; contemporary data investigating their molecular epidemiology are limited. Five hundred consecutive ceftriaxone-resistant (MIC ≥ 4 µg/mL) Enterobacterales bloodstream isolates were collected between 2018 and 2022 from three Maryland hospitals. Broth microdilution confirmed antibiotic susceptibilities.
View Article and Find Full Text PDFDevelopment of a qPCR assay to identify and differentiate insect-associated strains of the complex.
J Vet Diagn Invest
January 2025
Asia-Pacific Centre for Animal Health, Melbourne Veterinary School, Faculty of Science, University of Melbourne, Werribee, Victoria, Australia.
The complex contains important opportunistic pathogens of humans and vertebrate animals, as well as insects and other invertebrates. To date, the methods used for the identification of species within the genus , including PCR assays, have poor discriminatory power and may require further molecular typing or genomic sequence analysis to determine clinical relevance. We developed a duplex TaqMan probe-based quantitative real-time PCR (qPCR) assay targeting the gene, which is involved in chitin degradation and transport, and the gene, which is involved in urease production.
View Article and Find Full Text PDFLaboratory Exploration of Several Potential Biocontrol Methods Against the Ambrosia Beetle, .
Insects
January 2025
Co-Innovation Center for Sustainable Forestry in Southern China, College of Forestry, Nanjing Forestry University, Nanjing 210036, China.
The ambrosia beetle Blandford (Coleoptera: Curculionidae: Scolytinae) has recently emerged as a pest in Chinese poplar plantations, causing significant economic losses through damage to host trees in association with its mutualistic fungus . This study evaluated the biocontrol potential of strain B-BB-1, strain B-SM-1, its metabolite prodigiosin, and two ectoparasitic mites, and . exhibited significant lethality toward adult female , reduced offspring production, and inhibited growth.
View Article and Find Full Text PDFActivity of Aztreonam-avibactam and other β-lactamase inhibitor combinations against Gram-negative bacteria isolated from patients hospitalized with pneumonia in United States medical centers (2020-2022).
BMC Pulm Med
January 2025
Element Iowa City (JMI Laboratories), 345 Beaver Kreek Centre, Suite A North Liberty, Iowa, IA, 52317, USA.
Background: Initial antimicrobial therapy for pneumonia is frequently empirical and resistance to antimicrobial agents represents a great challenge to the treatment of patients hospitalized with pneumonia. We evaluated the frequency and antimicrobial susceptibility of Gram-negative bacteria causing pneumonia in US hospitals.
Methods: Bacterial isolates were consecutively collected (1/patient) from patients hospitalized with pneumonia and the susceptibility of Gram-negative bacilli (3,911 Enterobacterales and 2,753 non-fermenters) was evaluated by broth microdilution in a monitoring laboratory.
Synthesis and Biological Evaluation of Bile Acid-Triclosan Conjugates: A Study on Antibacterial, Antibiofilm, and Molecular Docking.
Bioconjug Chem
January 2025
Department of Biotechnology and Bioengineering, Institute of Advanced Research, Gandhinagar 382426, India.
This work describes the synthesis, characterization, and antibacterial properties of four bile acid-triclosan conjugates. The in vitro antibacterial activity of synthetic bile acid-triclosan conjugates was investigated against a panel of Gram-positive and Gram-negative bacteria. Conjugates and show high activity against (ATCC25922), with IC values of 2.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!